Pharma Product Plan Corporate

Open, View, and/or
Download this Document

Total Length: 701 words ( 2 double-spaced pages)

Total Sources: 2

Page 1 of 2

Pharma

The first thing that needs to be done is to understand how bioavailability helps with patient outcomes. This feature of the product needs to be translated to something concrete. There are two main outcomes of this class of pharmaceuticals. The first is that they reduce hypertension, and the second is that they reduce edema. Hypertension is already a major health issue in the U.S., so it probably has the best chance of success for gaining market share. Poor bioavailability means that the drug is probably less effective. A pill that delivers 100% bioavailability is actually quite remarkable. It would lower the cost of treatment in hospitals, which would otherwise need intravenous administration in order to achieve 100% bioavailability. So that is one angle - the cost benefit to hospitals. For direct comparison with the market leader, better bioavailability should translate to lower incidence of hypertension between the two drugs. There might be lower incidence of heart attacks and strokes as the result of better bioavailability. In addition, patients are probably going to report feeling better in general.

Stuck Writing Your "Pharma Product Plan" Corporate?

View All Our Example Pharma Product Plan Corporate

Have A Custom Example Essay Written

Translating fewer heart attacks and strokes is easy -- better quality of life, longer life, more time with family, less time in hospital. Nobody wants to be put at greater risk of heart attack and stroke.

2)

There are two approaches to better differentiation other than clinical benefits. Let's be realistic here -- gently pushing off-label uses is common practice in the industry. A drug that helps to lower blood pressure is going to have off-label uses if the only on-label uses are for patients with heart failure or renal insufficiency. So let's find some off-label uses and promote those through the usual unofficial and difficult-to-trace means. But if we want to remain completely legal about it -- and goodness knows a pharmaceutical company might theoretically decide to do this -- then differentiation can come in the form of branding or price. If the market perceives the product as a me-too, then pricing maybe should reflect that. Unfortunately, the competition is a generic, so being cost-competitive against a generic is not going….....

Show More ⇣

     Open the full completed essay and source list


OR

     Order a one-of-a-kind custom essay on this topic


sample essay writing service

Cite This Resource:

Latest APA Format (6th edition)

Copy Reference
"Pharma Product Plan" (2014, February 23) Retrieved June 17, 2024, from
https://www.aceyourpaper.com/essays/pharma-product-plan-183457

Latest MLA Format (8th edition)

Copy Reference
"Pharma Product Plan" 23 February 2014. Web.17 June. 2024. <
https://www.aceyourpaper.com/essays/pharma-product-plan-183457>

Latest Chicago Format (16th edition)

Copy Reference
"Pharma Product Plan", 23 February 2014, Accessed.17 June. 2024,
https://www.aceyourpaper.com/essays/pharma-product-plan-183457
   

Open, View, and/or
Download this Document
order custom essay example